Posts

Human Papillomavirus and Cytomegalovirus Therapeutics Market: Immunomodulators and Ganciclovir/Valganciclovir Held Major Shares of the Market - BioSpace

Image
Human Papillomavirus and Cytomegalovirus Therapeutics Market: Immunomodulators and Ganciclovir/Valganciclovir Held Major Shares of the Market - BioSpace Human Papillomavirus and Cytomegalovirus Therapeutics Market: Immunomodulators and Ganciclovir/Valganciclovir Held Major Shares of the Market - BioSpace HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus 16-Positive Cancers - BioSpace News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment - Cancer Research UK - Science Blog Human Papillomavirus and Cytomegalovirus Therapeutics Market: Immunomodulators and Ganciclovir/Valganciclovir Held Major Shares of the Market - BioSpace Posted: 28 Oct 2020 09:51 PM PDT Gene-Eden-VIR/Novirin Holds Promising Potential for Coronavirus Treatment The coronavirus (COVID-19) outbreak has caused a significant t...

Anal cancer on the rise in women, people older than 50 - Healio

Image
Anal cancer on the rise in women, people older than 50 - Healio Anal cancer on the rise in women, people older than 50 - Healio Posted: 29 Oct 2020 07:03 AM PDT October 29, 2020 2 min read Source/Disclosures Source: Raed A. P0399. Presented at: The American College of Gastroenterology Annual Scientific Meeting (Virtual). Oct. 26-28, 2020. Disclosures: Raed reports no relevant financial relationships. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio The incidence of anal cancer among women and those older than 50 years rose significantly from 2001 to 2...

Early post-therapy HPV clearance linked to improved survival in cervical cancer - Healio

Image
Early post-therapy HPV clearance linked to improved survival in cervical cancer - Healio Early post-therapy HPV clearance linked to improved survival in cervical cancer - Healio Posted: 15 Oct 2020 12:00 AM PDT October 15, 2020 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio Early post-therapy clearance of HPV appeared associated with improved survival among women with cervical cancer, according to results of a prospective study published in Cancer . Evaluation of HPV expression 6 weeks after treatment provided prognostic information beyond post-therap...

HPV vaccine helps prevent invasive cervical cancer, landmark study shows - The Guardian

Image
HPV vaccine helps prevent invasive cervical cancer, landmark study shows - The Guardian HPV vaccine helps prevent invasive cervical cancer, landmark study shows - The Guardian Posted: 01 Oct 2020 12:00 AM PDT Vaccinating populations against the human papillomavirus, which causes most cases of cervical cancer, is effective and saves lives, according to a milestone Swedish study. The results were welcomed as a significant moment in the fight to eradicate cervical cancer, which kills more than 250,000 women a year. The large-scale study by the Karolinska Institutet found that women vaccinated against HPV have a significantly lower risk of developing cervical cancer, with women vaccinated at a young age benefiting the most. Jiayao Lei, a researcher at the department of medical epidemiology and biostatistics at Karolinska Institutet, said the study was the first to show that HPV vaccination helped protect against invasive cervical cancer, not...

Transgene's Vaccine for HPV16-Related Cancers Shows Anti-Tumor Activity With Bavencio - Precision Oncology News

Image
Transgene's Vaccine for HPV16-Related Cancers Shows Anti-Tumor Activity With Bavencio - Precision Oncology News Transgene's Vaccine for HPV16-Related Cancers Shows Anti-Tumor Activity With Bavencio - Precision Oncology News Posted: 27 Oct 2020 11:30 AM PDT NEW YORK – Transgene on Tuesday reported that the combination of its therapeutic vaccine TG4001 and the monoclonal antibody avelumab (EMD Serono/Pfizer's Bavencio) demonstrated activity in patients with previously treated, recurrent or metastatic human papillomavirus-related cancers. The Phase Ib/II trial enrolled 34 patients with HPV16-positive anal, oropharyngeal, cervical, vulvar, or vaginal cancers, most of whom had received at least one line of previous treatment. All patients received TG4001 and avelumab, and eight experienced tumor shrinkage with the combo, resulting in an overall response rate of 23.5 percent. One patient had a complete response and seven had ...

Should HPV self-testing be usual care in the US? - Healio

Image
Should HPV self-testing be usual care in the US? - Healio Should HPV self-testing be usual care in the US? - Healio Gynecologic oncologists seek balance as cervical cancer screening guidelines evolve - Healio It's Essential to Get Vaccinated for HPV, Even During a Pandemic : SF STAT! - South Florida Hospital News Should HPV self-testing be usual care in the US? - Healio Posted: 25 Oct 2020 12:00 AM PDT October 27, 2020 4 min read Source/Disclosures Disclosures: Einstein reports no relevant financial disclosures. Young Pierce reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you contin...